110 related articles for article (PubMed ID: 7613575)
1. [Value of IGF I in gynecology and obstetrics].
Bettahar-Lebugle K; Ohl J; Moreau L; Dellenbach P
Contracept Fertil Sex; 1995 May; 23(5):302-6. PubMed ID: 7613575
[No Abstract] [Full Text] [Related]
2. [Use of oral contraceptives and risk of cancer].
Bjørge T; Engeland A
Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1788-90. PubMed ID: 12362690
[No Abstract] [Full Text] [Related]
3. Oncological repercussions of polycystic ovary syndrome.
de França Neto AH; Rogatto S; Do Amorim MM; Tamanaha S; Aoki T; Aldrighi JM
Gynecol Endocrinol; 2010 Oct; 26(10):708-11. PubMed ID: 20528205
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
[TBL] [Abstract][Full Text] [Related]
5. [Female genital cancer and life style factors. New discoveries in epidemiological front-line research].
Wilhelmson B
Lakartidningen; 1995 Mar; 92(12):1248-55. PubMed ID: 7707768
[No Abstract] [Full Text] [Related]
6. The role of calprotectin in obstetrics and gynecology.
Kostakis ID; Cholidou KG; Kallianidis K; Perrea D; Antsaklis A
Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):3-9. PubMed ID: 20378239
[TBL] [Abstract][Full Text] [Related]
7. Present status of oral contraceptives: 2. Complications, special considerations, relationship to cancer, cautions.
Kistner RW
Drug Ther (NY); 1972 Jan; 2(1):42. PubMed ID: 12229384
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin in obstetrics and gynaecology.
Bose CK
J Stem Cells; 2009; 4(4):217-27. PubMed ID: 20720595
[TBL] [Abstract][Full Text] [Related]
9. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and gynecological cancers: is there a link?
Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR
Gynecol Endocrinol; 2005 Apr; 20(4):200-8. PubMed ID: 16019362
[TBL] [Abstract][Full Text] [Related]
11. The polycystic ovary syndrome and gynecological cancer risk.
Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: relationship to growth hormone, insulin-like growth factor-I, and insulin.
Tjaden B
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):279-83. PubMed ID: 8038416
[TBL] [Abstract][Full Text] [Related]
13. [Ovarian cortical sclerosis. Etiological considerations].
Belaisch J; Malier P
Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(1):9-16. PubMed ID: 5685141
[No Abstract] [Full Text] [Related]
14. Environmentally related cancer in women.
Environ Health Perspect; 1993 Jun; 101(2):110-1. PubMed ID: 8354190
[No Abstract] [Full Text] [Related]
15. [The effects of hyperinsulinmia and insulin-like growth factor-1 on hyperandrogenism in polycystic ovarian syndrome].
Liang X; Zhuang G; Fan Q
Zhonghua Yi Xue Za Zhi; 1997 Apr; 77(4):266-9. PubMed ID: 9596926
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for the development of malignant neoplasms of the reproductive organs in women].
Maksimov SIa; Guseĭnov KD; Kosnikov AG; Antoneeva II; Khadzhimba AS
Vopr Onkol; 2003; 49(4):496-501. PubMed ID: 14569945
[No Abstract] [Full Text] [Related]
17. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
Schoyer KD; Liu HC; Witkin S; Rosenwaks Z; Spandorfer SD
Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome and cancer.
Balen A
Hum Reprod Update; 2001; 7(6):522-5. PubMed ID: 11727859
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome and the postmenopausal woman.
Ireland K; Child T
J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
